ARDX insider transaction filings
ARDELYX, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-25. Screen ARDX transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 9 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 22 legs across 9 filings by 8 insiders — 167,727 shares, $697,120 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 41,668 shares @ $5.06 ($210,923) by RAAB MICHAEL, filed 2026-07-17.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| RAAB MICHAEL — President & CEO, Director | 2 | — | 5 legs · 100,242 sh · $436,837 | 2 |
| Bishop John E — See Remarks | 1 | — | 2 legs · 19,750 sh · $76,174 | — |
| Brady James Parker — Chief Human Resources Officer | 1 | — | 2 legs · 15,136 sh · $58,378 | — |
| Williams Laura A — Chief Patient Officer | 1 | — | 4 legs · 10,739 sh · $41,419 | — |
| Foster Eric Duane — Chief Commercial Officer | 1 | — | 3 legs · 8,562 sh · $33,023 | — |
| Kelliher Mike — Chief Business Officer | 1 | — | 3 legs · 7,758 sh · $29,922 | — |
| Reilly Joseph James — See Remarks | 1 | — | 2 legs · 3,982 sh · $15,358 | — |
| Hohenleitner Susan — Chief Financial Officer | 1 | — | 1 leg · 1,558 sh · $6,009 | — |
Recent Form 4 filings — ARDELYX, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-25 | 4 | Reilly Joseph James — See Remarks | Sale (S): 2,872 @ $3.86 · Sale (S): 1,110 @ $3.86 | EDGAR |
| 2026-08-25 | 4 | Hohenleitner Susan — Chief Financial Officer | Sale (S): 1,558 @ $3.86 | EDGAR |
| 2026-08-25 | 4 | Brady James Parker — Chief Human Resources Officer | Sale (S): 1,976 @ $3.86 · Sale (S): 13,160 @ $3.86 | EDGAR |
| 2026-08-25 | 4 | Bishop John E — See Remarks | Sale (S): 17,281 @ $3.86 · Sale (S): 2,469 @ $3.86 | EDGAR |
| 2026-08-25 | 4 | Foster Eric Duane — Chief Commercial Officer | Sale (S): 2,598 @ $3.86 · Sale (S): 3,389 @ $3.86 · Sale (S): 2,575 @ $3.86 | EDGAR |
| 2026-08-25 | 4 | Williams Laura A — Chief Patient Officer | Sale (S): 3,486 @ $3.86 · Sale (S): 3,089 @ $3.86 · Sale (S): 2,430 @ $3.86 · Sale (S): 1,734 @ $3.86 | EDGAR |
| 2026-08-25 | 4 | Kelliher Mike — Chief Business Officer | Sale (S): 3,104 @ $3.86 · Sale (S): 2,652 @ $3.86 · Sale (S): 2,002 @ $3.86 | EDGAR |
| 2026-08-25 | 4 | RAAB MICHAEL — President & CEO, Director | Sale (S): 15,009 @ $3.86 · Sale (S): 15,976 @ $3.86 · Sale (S): 8,411 @ $3.86 · Sale (S): 19,178 @ $3.86 | EDGAR |
| 2026-07-17 | 4 | RAAB MICHAEL — President & CEO, Director | Option exercise (M): 20,834 @ $0.99 · Sale (S): 41,668 @ $5.06 · Option exercise (M): 20,834 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Williams Laura A — Chief Patient Officer | Option exercise (M): 31,000 @ $0.99 · Sale (S): 81,898 @ $5.99 · Option exercise (M): 31,000 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Bhanji Muna — Director | Grant/award (A): 26,455 @ $0 · Grant/award (A): 39,715 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Cadoret-Manier Onaiza — Director | Grant/award (A): 26,455 @ $0 · Grant/award (A): 39,715 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Parsey Merdad — Director | Grant/award (A): 26,455 @ $0 · Grant/award (A): 39,715 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Bazemore Robert B — Director | Grant/award (A): 26,455 @ $0 · Grant/award (A): 39,715 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Rodgers Richard J — Director | Grant/award (A): 26,455 @ $0 · Grant/award (A): 39,715 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Bertrand William C JR — Director | Grant/award (A): 12,345 @ $0 · Grant/award (A): 26,455 @ $0 · Grant/award (A): 39,715 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | MOTT DAVID M — Director | Grant/award (A): 20,282 @ $0 · Grant/award (A): 26,455 @ $0 · Grant/award (A): 39,715 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | RAAB MICHAEL — President & CEO, Director | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $5.67 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Hohenleitner Susan — Chief Financial Officer | Sale (S): 1,455 @ $6.27 | EDGAR |
| 2026-05-22 | 4 | Brady James Parker — Chief Human Resources Officer | Sale (S): 1,846 @ $6.27 | EDGAR |
| 2026-05-22 | 4 | Reilly Joseph James — See Remarks | Sale (S): 2,683 @ $6.27 · Sale (S): 1,036 @ $6.27 | EDGAR |
| 2026-05-22 | 4 | Foster Eric Duane — Chief Commercial Officer | Sale (S): 3,166 @ $6.27 · Sale (S): 2,427 @ $6.27 · Sale (S): 2,405 @ $6.27 | EDGAR |
| 2026-05-22 | 4 | Kelliher Mike — Chief Business Officer | Sale (S): 2,900 @ $6.27 · Sale (S): 1,870 @ $6.27 · Sale (S): 2,478 @ $6.27 | EDGAR |
| 2026-05-22 | 4 | Williams Laura A — Chief Patient Officer | Sale (S): 1,503 @ $6.27 · Sale (S): 2,157 @ $6.27 · Sale (S): 1,911 @ $6.27 · Sale (S): 1,418 @ $6.27 | EDGAR |
| 2026-05-22 | 4 | RAAB MICHAEL — President & CEO, Director | Sale (S): 14,933 @ $6.27 · Sale (S): 7,861 @ $6.27 · Sale (S): 17,926 @ $6.27 · Sale (S): 14,028 @ $6.27 | EDGAR |
| 2026-05-22 | 4 | Bishop John E — See Remarks | Sale (S): 2,306 @ $6.27 | EDGAR |
| 2026-05-19 | 4 | RAAB MICHAEL — President & CEO, Director | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $6.28 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | RAAB MICHAEL — President & CEO, Director | Option exercise (M): 20,834 @ $0.99 · Sale (S): 41,668 @ $6.29 · Option exercise (M): 20,834 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4 | RAAB MICHAEL — President & CEO, Director | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $5.84 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | RAAB MICHAEL — President & CEO, Director | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $6.25 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Reilly Joseph James — See Remarks | Sale (S): 4,387 @ $5.87 · Sale (S): 602 @ $5.71 · Sale (S): 2 @ $5.70 | EDGAR |
| 2026-02-23 | 4 | Williams Laura A — See Remarks | Sale (S): 7,192 @ $5.87 · Sale (S): 984 @ $5.71 | EDGAR |
| 2026-02-23 | 4 | Hohenleitner Susan — Chief Financial Officer | Sale (S): 1,786 @ $5.87 · Sale (S): 247 @ $5.71 | EDGAR |
| 2026-02-23 | 4 | Brady James Parker — Chief Human Resources Officer | Sale (S): 2,234 @ $5.87 · Sale (S): 309 @ $5.71 | EDGAR |
| 2026-02-23 | 4 | Kelliher Mike — See Remarks | Sale (S): 8,434 @ $5.87 · Sale (S): 1,159 @ $5.71 · Sale (S): 2 @ $5.71 | EDGAR |
| 2026-02-23 | 4 | Foster Eric Duane — Chief Commercial Officer | Sale (S): 9,176 @ $5.87 · Sale (S): 1,261 @ $5.71 · Sale (S): 1 @ $5.71 · Sale (S): 1 @ $5.70 | EDGAR |
| 2026-02-23 | 4 | RAAB MICHAEL — President & CEO, Director | Sale (S): 40,401 @ $5.87 · Sale (S): 5,576 @ $5.71 · Sale (S): 2 @ $5.70 · Sale (S): 1 @ $5.70 · Sale (S): 2 @ $5.70 | EDGAR |
| 2026-02-23 | 4 | Bishop John E — See Remarks | Sale (S): 2,792 @ $5.87 · Sale (S): 386 @ $5.71 · Sale (S): 1 @ $5.70 | EDGAR |
| 2026-02-23 | 4 | MOTT DAVID M — Director | Purchase (P): 333,333 @ $5.84 | EDGAR |
| 2026-01-27 | 4 | Reilly Joseph James — See Remarks | Grant/award (A): 46,200 @ $0 · Grant/award (A): 69,360 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Kelliher Mike — See Remarks | Grant/award (A): 103,080 @ $0 · Grant/award (A): 154,625 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Hohenleitner Susan — Chief Financial Officer | Grant/award (A): 85,670 @ $0 · Grant/award (A): 128,505 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Foster Eric Duane — Chief Commercial Officer | Grant/award (A): 137,945 @ $0 · Grant/award (A): 206,915 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Brady James Parker — Chief Human Resources Officer | Grant/award (A): 99,455 @ $0 · Grant/award (A): 149,185 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Williams Laura A — Chief Patient Officer | Grant/award (A): 82,695 @ $0 · Grant/award (A): 124,040 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | RAAB MICHAEL — President & CEO, Director | Grant/award (A): 446,220 @ $0 · Grant/award (A): 669,330 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Bishop John E — See Remarks | Grant/award (A): 124,330 @ $0 · Grant/award (A): 186,500 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Williams Laura A — Chief Patient Officer | Option exercise (M): 50,000 @ $0.99 · Sale (S): 50,000 @ $6.98 · Option exercise (M): 0 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | RAAB MICHAEL — President & CEO, Director | Sale (S): 46,887 @ $5.54 | EDGAR |
| 2025-11-25 | 4 | GRAMMER ELIZABETH A — See Remarks | Sale (S): 5,995 @ $5.54 | EDGAR |
Recent 8-K events — ARDELYX, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-17 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-19 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ARDX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →